keyword
https://read.qxmd.com/read/38615487/nlr-outperforms-low-hemoglobin-and-high-platelet-count-as-predictive-and-prognostic-biomarker-in-metastatic-renal-cell-carcinoma-treated-with-immune-checkpoint-inhibitors
#21
JOURNAL ARTICLE
Matthew Young, Jose C Tapia, Bernadett Szabados, Agne Jovaisaite, Francesca Jackson-Spence, Elizabeth Nally, Thomas Powles
BACKGROUND: Reliable biomarkers in renal cell carcinoma (RCC) remain elusive. While several markers have been shown to be associated with prognosis, and may aid in risk assessment, predictive biomarkers of response to immune checkpoint inhibitors (ICIs) have not been established. Previous studies have shown that a high pretreatment neutrophil-lymphocyte ratio (NLR) is a negative prognostic factor in RCC. However, a clinically useful cut-off for the predictive and prognostic value of NLR has not been well defined...
March 8, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38614853/impact-of-preoperative-plasma-potassium-levels-on-oncological-outcomes-major-complications-and-30-day-mortality-in-bladder-cancer-patients-undergoing-radical-cystectomy
#22
JOURNAL ARTICLE
Jakob Klemm, Shahrokh F Shariat, Ekaterina Laukhtina, Pawel Rajwa, Malte W Vetterlein, Victor M Schuettfort, Markus von Deimling, Roland Dahlem, Margit Fisch, Michael Rink
INTRODUCTION AND OBJECTIVES: We examined the impact of preoperative plasma potassium levels (PPLs) on outcomes in patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB), hypothesizing that potassium imbalances might influence outcomes. PATIENTS AND METHODS: In this retrospective study, 501 UCB patients undergoing RC from 2009 to 2017 at a tertiary center were analyzed. Blood samples collected a week prior to surgery defined normal and abnormal PPL based on institutional standards...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38611608/dependence-of-renal-uptake-on-kidney-function-in-68-ga-ga-psma-11-pet-ct-imaging
#23
JOURNAL ARTICLE
Falk Gühne, Till Schilder, Philipp Seifert, Christian Kühnel, Martin Freesmeyer
(1) Background: PSMA ligand PET/CT is increasingly important for diagnostics of prostate cancer and other tumor diseases. In particular, the radiopharmaceutical [68 Ga]Ga-PSMA-11 is widely used. Besides its tumor-specific binding, the uptake within the kidneys is dominant and seems to visualize the renal cortex specifically. Kidney diseases may alter the uptake of radiopharmaceuticals. Therefore, the correlation between renal uptake in PET/CT imaging and renal function should be investigated. (2) Methods: A group of 103 male patients were retrospectively evaluated for eGFR according to the CKD-EPI equation, tracer uptake intensity (SUVmax , SUVpeak , SUVmean ), the molecular volume of the renal cortex, morphological kidney size, and total renal uptake...
March 26, 2024: Diagnostics
https://read.qxmd.com/read/38608334/detection-of-the-highest-grade-lesion-in-multifocal-discordant-prostate-cancer-by-multiparametric-magnetic-resonance-imaging
#24
JOURNAL ARTICLE
Kazuhiro Matsumoto, Hirotaka Akita, Akinori Hashiguchi, Toshikazu Takeda, Takeo Kosaka, Keishiro Fukumoto, Yota Yasumizu, Nobuyuki Tanaka, Shinya Morita, Ryuichi Mizuno, Hiroshi Asanuma, Mototsugu Oya, Masahiro Jinzaki
PURPOSE: Prostate cancer generally occurs multifocally. The lesions of the largest size and highest-grade are often concordant, and defined as an index tumor. However, these factors sometimes do not coincide within one lesion. In such discordant cases, not the largest size lesion but the highest-grade lesion is known to determine the prognosis. We focused on the multiparametric magnetic resonance imaging (mpMRI) detectability of the highest-grade tumors in discordant cases. MATERIALS AND METHODS: We investigated the detectability of the highest-grade tumor using preoperative mpMRI in 50 discordant patients who underwent radical prostatectomy...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38606859/secondary-cancer-after-androgen-deprivation-therapy-in-prostate-cancer-a-nationwide-study
#25
JOURNAL ARTICLE
Jae Heon Kim, Gi Hwan Bae, Jaehun Jung, Tae Il Noh
PURPOSE: Androgen signaling is associated with various secondary cancer, which could be promising for potential treatment using androgen deprivation therapy (ADT). This study investigated whether ADT use was associated with secondary cancers other than prostate cancer in a nationwide population-based cohort. MATERIALS AND METHODS: A total, 278,434 men with newly diagnosed prostate cancer between January 1, 2002 and December 31, 2017 were identified. After applying the exclusion criteria, 170,416 men were enrolled...
March 14, 2024: World Journal of Men's Health
https://read.qxmd.com/read/38602729/-discussion-on-the-biological-basis-of-chronic-prostatitis-based-on-the-brain-centre-kidney-vessel-axis
#26
JOURNAL ARTICLE
Zi-Wei Zhao, Qing-He Gao, Fu Wang, Jun Guo
Chronic prostatitis is a common disease in male clinics. The theory of "brain-centre-kidney-vessel" axisis based on the basic theories of traditional Chinese medicine, the pathogenesis of modern men's diseases, and the theory of traditional Chinese medicine in men's medicine proposed by clinical practice. It takes the "brain-heart-kidney-vessel" axis as the entry point, the use of the vessel as the core pathogenesis, the meridians as the link, and the dysfunction of the brain, heart, and kidneys as the important conditions, and proposes that the biological basis between chronic prostatitis and the "brain-heart-kidney-vessel" axis is related to neurological, endocrine, and immunological disorders, as well as the biological basis of the "brain-heart-kidney-vessel" axis...
June 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38598830/clinical-safety-and-efficacy-of-microwave-ablation-for-small-renal-masses
#27
JOURNAL ARTICLE
Ashley Foret, Christopher B Haaga, Shivani Jain, Chelsea O Baumgartner, Megan Escott, Benjamin R Henderson, Sean T O'Brien, Scott E Delacroix, Jessie R R Gills, Mary E Westerman
PURPOSE: CT-guided MWA is a safe and effective tool that should be utilized in the treatment of small renal masses (SRMs). We aim to clarify the utility of CT-guided MWA by examining patient outcomes such as recurrence, treatment success, changes in renal function, and complications. METHODS: A retrospective review of consecutive patients with SRMs who underwent same day renal mass biopsy (RMB) and CT-guided MWA between 2015 and 2022 was performed. Treatment safety was assessed by 30-day complications according to the Clavien-Dindo system and change in eGFR >30 days post-procedure...
2024: International Braz J Urol: Official Journal of the Brazilian Society of Urology
https://read.qxmd.com/read/38597666/have-the-recent-advancements-in-cancer-therapy-and-survival-benefitted-patients-of-all-age-groups-across-the-nordic-countries-nordcan-survival-analyses-2002-2021
#28
JOURNAL ARTICLE
Anna L V Johansson, Simon M Kønig, Siri Larønningen, Gerda Engholm, Niels Kroman, Karri Seppä, Nea Malila, Bjarni Á Steig, Eva Maria Gudmundsdóttir, Elínborg J Ólafsdóttir, Frida E Lundberg, Therese M-L Andersson, Paul C Lambert, Mats Lambe, David Pettersson, Bjarte Aagnes, Søren Friis, Hans Storm
BACKGROUND: Since the early 2000s, overall and site-specific cancer survival have improved substantially in the Nordic countries. We evaluated whether the improvements have been similar across countries, major cancer types, and age groups. MATERIAL AND METHODS: Using population-based data from the five Nordic cancer registries recorded in the NORDCAN database, we included a cohort of 1,525,854 men and 1,378,470 women diagnosed with cancer (except non-melanoma skin cancer) during 2002-2021, and followed for death until 2021...
April 10, 2024: Acta Oncologica
https://read.qxmd.com/read/38593599/an-update-on-the-role-of-mpmri-and-68-ga-psma-pet-imaging-in-primary-and-recurrent-prostate-cancer
#29
REVIEW
Hamed Bagheri, Seyed Rabi Mahdavi, Parham Geramifar, Ali Neshasteh-Riz, Masoumeh Sajadi Rad, Habibollah Dadgar, Hossein Arabi, Habib Zaidi
The objective of this work was to review comparisons of the efficacy of 68 Ga-PSMA-11 (prostate-specific membrane antigen) PET/CT and multiparametric magnetic resonance imaging (mpMRI) in the detection of prostate cancer among patients undergoing initial staging prior to radical prostatectomy or experiencing recurrent prostate cancer, based on histopathological data. A comprehensive search was conducted in PubMed and Web of Science, and relevant articles were analyzed with various parameters, including year of publication, study design, patient count, age, PSA (prostate-specific antigen) value, Gleason score, standardized uptake value (SUVmax ), detection rate, treatment history, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and PI-RADS (prostate imaging reporting and data system) scores...
March 13, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38589511/visual-extended-reality-tools-in-image-guided-surgery-in-urology-a-systematic-review
#30
REVIEW
Enrico Checcucci, Alberto Piana, Gabriele Volpi, Alberto Quarà, Sabrina De Cillis, Federico Piramide, Mariano Burgio, Juliette Meziere, Edoardo Cisero, Marco Colombo, Gabriele Bignante, Michele Sica, Stefano Granato, Paolo Verri, Cecilia Gatti, Paolo Alessio, Michele Di Dio, Stefano Alba, Cristian Fiori, Daniele Amparore, Francesco Porpiglia
PURPOSE: The aim of this systematic review is to assess the clinical implications of employing various Extended Reality (XR) tools for image guidance in urological surgery. METHODS: In June 2023, a systematic electronic literature search was conducted using the Medline database (via PubMed), Embase (via Ovid), Scopus, and Web of Science. The search strategy was designed based on the PICO (Patients, Intervention, Comparison, Outcome) criteria. Study protocol was registered on PROSPERO (registry number CRD42023449025)...
April 9, 2024: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38584004/cardiovascular-toxicity-associated-with-androgen-receptor-axis-targeted-agents-in-patients-with-prostate-cancer-a-meta-analysis-of-randomized-controlled-trials
#31
JOURNAL ARTICLE
Susu Zhou, Parissa Alerasool, Noriko Kishi, Himanshu Joshi, Gagan Sahni, Che-Kai Tsao
INTRODUCTION: Second-generation androgen receptor axis-targeting (ARAT) agents have become a standard treatment for patients with advanced prostate cancer (PC), however much remains unknown about the potential cardiovascular toxicities. PATIENTS AND METHODS: We performed a systematic search of PubMed, Embase, Web of Science, and Cochrane library for randomized controlled trials of patients receiving ARAT agents for PC from inception to March 2023. The odds ratios (ORs) of all-grade and high-grade cardiovascular adverse events (CVAEs) for patients treated with and without ARAT agents were pooled for meta-analysis...
March 8, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38580522/effectiveness-of-adjuvant-chemotherapy-in-variant-histology-upper-tract-urothelial-carcinoma-following-radical-nephroureterectomy-stabilized-inverse-probability-treatment-weighting-analysis-of-single-center-experience
#32
JOURNAL ARTICLE
Inkeun Park, Jungyo Suh, Bumjin Lim, Cheryn Song, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Yong Mee Cho, Jaelyun Lee, Bumsik Hong
PURPOSE: The study aimed to investigate the impact of adjuvant chemotherapy on time to recurrence (TTR) and overall survival (OS) in patients with histologic variants of upper tract urothelial carcinoma (VUTUC) following radical nephroureterectomy (RNU). MATERIALS AND METHODS: A retrospective review of 131 VUTUC patients' medical records, from a pool of 368 non-metastatic localized or locally advanced UTUC cases, treated at a single tertiary referral center between January 2011 and January 2021...
March 4, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38578393/novel-clinical-risk-calculator-for-improving-cancer-predictability-of-mpmri-fusion-biopsy-in-prostates
#33
JOURNAL ARTICLE
Anthony Bruccoliere, Vivie Tran, Naseem Helo, Abdul Awal, Stephanie Stroever, Werner T W de Riese
PURPOSE: Prostate Imaging-Reporting and Data System (PI-RADS) assists in evaluating lesions on multiparametric magnetic resonance imaging (mpMRI), but there are still ongoing efforts in improving the predictive value for the presence of clinically significant PCa (csPCa) with a Gleason grade group ≥ 2 on Fusion-Biopsy. This pilot study intends to propose an easily implementable method for augmenting predictability of csPCa for PI-RADS. METHODS: A cohort of 151 consecutive patients underwent mpMRI Fusion and random US Biopsy as a result of having at least one PI-RADS lesion grade 3-5 between January 1, 2019 and December 31, 2022...
April 5, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38576236/clinically-undiagnosed-diseases-in-autopsies-frequency-and-risk-factors
#34
JOURNAL ARTICLE
Umberto Maccio, Christoph Andreas Meier, Michael Reinehr, Frank Ruschitzka, Reto Schüpbach, Holger Moch, Zsuzsanna Varga
CONTEXT.—: Autopsies can reveal clinically undiagnosed diseases. However, the frequency of first diagnoses at autopsy and their association with clinically known risk factors are not well understood because of lack of systematic analyses addressing this topic. OBJECTIVE.—: To perform a large retrospective cohort analysis on the frequency of clinically undiagnosed postmortem findings and correlate these with patients' risk factors. DESIGN...
April 5, 2024: Archives of Pathology & Laboratory Medicine
https://read.qxmd.com/read/38573543/causal-effect-of-gut-microbiota-on-the-risk-of-prostatitis-a-two-sample-mendelian-randomization-study
#35
JOURNAL ARTICLE
Dalu Liu, Yangyang Mei, Nuo Ji, Bo Zhang, Xingliang Feng
BACKGROUND: Recent studies demonstrated that chronic prostatitis (CP) is closely related to the gut microbiota (GM). Nevertheless, the causal relationship between GM and CP has not been fully elucidated. Therefore, the two-sample Mendelian randomization (MR) analysis was employed to investigate this association. METHODS: The summary data of gut microbiota derived from a genome-wide association study (GWAS) involving 18,340 individuals in the MiBioGen study served as the exposure, and the corresponding summary statistics for CP risk, representing the outcome, were obtained from the FinnGen databases (R9)...
April 4, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38570733/novel-cdk19-targeted-radiotracers-a-potential-design-strategy-to-improve-the-pharmacokinetics-and-tumor-uptake
#36
JOURNAL ARTICLE
Dong Dai, Jiang Yu, Wenfeng Gou, Shuangmeng Yang, Yanli Li, Ziyang Wang, Zhao Yang, Ting Huang, Panfeng Li, Tong Zhu, Wenbin Hou, Yu Zhao, Wengui Xu, Yiliang Li
Cyclin-dependent kinase 19 (CDK19) is overexpressed in prostate cancer, making it an attractive target for both imaging and therapy. Since little is known about the optimized approach for radioligands of nuclear proteins, linker optimization strategies were used to improve pharmacokinetics and tumor absorption, including the adjustment of the length, flexibility/rigidity, and hydrophilicity/lipophilicity of linkers. Molecular docking was conducted for virtual screening and followed by IC50 determination. Both BALB/c mice and P-16 xenografts were used for tissue distribution and PET/CT imaging...
April 3, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38568428/bone-marrow-dosimetry-in-low-volume-mhspc-patients-receiving-lu-177-psma-therapy-using-spect-ct
#37
JOURNAL ARTICLE
Dagmar Grob, Bastiaan M Privé, Constantijn H J Muselaers, Niven Mehra, James Nagarajah, Mark W Konijnenberg, Steffie M B Peters
BACKGROUND: Bone marrow toxicity in advanced prostate cancer patients who receive [177 Lu]Lu-PSMA-617 is a well-known concern. In early stage patients; e.g. low volume metastatic hormone sensitive prostate cancer (mHSPC) patients, prevention of late bone marrow toxicity is even more crucial due to longer life expectancy. To date, bone marrow dosimetry is primarily performed using blood sampling. This method is time consuming and does not account for possible active bone marrow uptake...
April 3, 2024: EJNMMI Physics
https://read.qxmd.com/read/38567745/acute-kidney-injury-after-robot-assisted-laparoscopic-prostatectomy-a-meta-analysis
#38
JOURNAL ARTICLE
Deepak Chandramohan, Raghunandan Konda, Ashwini Pujari, Sreekant Avula, Sujith Kumar Palleti, Nihar Jena, Roopa Naik, Atul Bali
BACKGROUND: We investigated the rates of acute kidney injury (AKI) post robot-assisted laparoscopic prostatectomy (RALP). METHODS: A comprehensive search was conducted to identify studies that reported the rates of AKI post-RALP. A random effects model was used, and the pooled rates of AKI were calculated. RESULTS: We identified 10 studies with 60,937 patients to be included. The mean age was 65.1 years. The mean anaesthesia time was 234...
April 2024: International Journal of Medical Robotics + Computer Assisted Surgery: MRCAS
https://read.qxmd.com/read/38567167/synchronous-papillary-thyroid-cancer-and-colorectal-cancer-in-a-young-patient-with-a-chek2-mutation
#39
Sydney Brooke Hoskins, Leslie Torgerson
INTRODUCTION: Mutations of CHEK2 are usually inherited and have been implicated in breast cancers, colorectal cancers, thyroid cancers, kidney cancers, and prostate cancers. The CHEK2 gene codes for checkpoint kinase 2 protein which is an effector in the ATM-CHEK2-p53 pathway and responds to DNA double-strand breaks. CASE PRESENTATION: We describe a unique case of a 29-year-old Canadian female who presented with synchronous papillary thyroid carcinoma and rectal adenocarcinoma who was subsequently found to have a sporadic CHEK2 (checkpoint kinase 2) mutation...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38564079/adequacy-of-prostate-cancer-prevention-and-screening-recommendations-provided-by-an-artificial-intelligence-powered-large-language-model
#40
JOURNAL ARTICLE
Giuseppe Chiarelli, Alex Stephens, Marco Finati, Giuseppe Ottone Cirulli, Edoardo Beatrici, Dejan K Filipas, Sohrab Arora, Shane Tinsley, Mahendra Bhandari, Giuseppe Carrieri, Quoc-Dien Trinh, Alberto Briganti, Francesco Montorsi, Giovanni Lughezzani, Nicolò Buffi, Craig Rogers, Firas Abdollah
PURPOSE: We aimed to assess the appropriateness of ChatGPT in providing answers related to prostate cancer (PCa) screening, comparing GPT-3.5 and GPT-4. METHODS: A committee of five reviewers designed 30 questions related to PCa screening, categorized into three difficulty levels. The questions were formulated identically for both GPTs three times, varying the prompts. Each reviewer assigned a score for accuracy, clarity, and conciseness. The readability was assessed by the Flesch Kincaid Grade (FKG) and Flesch Reading Ease (FRE)...
April 2, 2024: International Urology and Nephrology
keyword
keyword
22503
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.